Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
| author |
|
| created | [InstanceEdit:9733469] Stephan, Ralf, 2021-06-04 |
| dbId | 9733490 |
| displayName | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| journal | Cell Res |
| pages | 343-355 |
| pubMedIdentifier | 32231345 |
| schemaClass | LiteratureReference |
| title | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| url | http://www.ncbi.nlm.nih.gov/pubmed/32231345 |
| volume | 30 |
| year | 2020 |
Referrals
© 2026 Reactome
